Krystal Biotech
Manufacturing · Pennsylvania, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2100 Wharton St Ste 701, Pittsburgh, Pen...Phone Number
(412) 586-5830Website
www.krystalbio.comRevenue
$440.5 MillionStock Symbol
KRYSIndustry
About Krystal Biotech
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in PittsRead more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: KRYSShow moreKrystal Biotech Org Chart
Compare Similar Companies to Krystal Biotech
Compare insights from companies similar to Krystal Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$15.5M
51-200
Private
$31M
2003
JH
Jim HavilandVice President, Quality Assurance, Regulatory Compliance & Regulatory Affairs
Krystal Biotech Tech Stack
A closer look at the technologies used by Krystal Biotech
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Krystal Biotech
Sign Up For FreeTo access detailed company insights
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Ph... Read More